Wednesday, July 8, 2026

Intelligence · Clinical Development

Pipeline search results

Programs matching “asthma” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.

Matching programs 226
Total indexed 20,548
Sponsors 1,769

Quick answer

Showing 226 pipeline programs matching "asthma" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.

Refine search

226 results for “asthma” Back to intelligence hub

Search results

Page 1 of 10
  1. 0.9% sodium chloride, GB-0895

    Generate Biomedicines

    severe uncontrolled asthma

    phase 3 small molecule active

    1 trial
  2. 0600-PG-PSC-218

    Lacuna Pharma Pty Ltd

    Allergic rhinoconjunctivitis with or without controlled asthma

    phase 3 small molecule active

    1 trial
  3. 060018-PG-PSC-217

    Lacuna Pharma Pty Ltd

    Allergic rhinoconjunctivitis with or without asthma due to clinically relevant sensitisation to grass and olive pollen.

    phase 3 small molecule active

    1 trial
  4. 206785

    GlaxoSmithKline

    Severe asthma with an eosinophilic phenotype

    phase 3 small molecule active

    1 trial
  5. 212895

    GlaxoSmithKline

    Severe asthma with an eosinophilic phenotype

    phase 3 other active

    1 trial
  6. 220735

    GlaxoSmithKline

    Asthma

    phase 3 small molecule active

    1 trial
  7. 223529

    GlaxoSmithKline

    Asthma with type 2 inflammation characterized by an eosinophilic phenotype

    phase 3 other active

    1 trial
  8. 610

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Asthma

    phase 3 small molecule active

    2 trials
  9. Albuterol

    Teva Pharma GmbH

    Asthma

    phase 3 small molecule completed

    2 trials
  10. Albuterol MDPI

    Teva Pharma GmbH

    Asthma

    phase 3 small molecule completed

    1 trial
  11. Albuterol Spiromax®

    Teva Pharma GmbH

    Asthma

    phase 3 small molecule completed

    4 trials
  12. Albuterol Sulfate

    Teva Pharma GmbH

    Asthma

    phase 3 small molecule completed

    1 trial
  13. Armstrong Albuterol Sulfate Inhalation Aerosol

    Amphastar France Pharmaceuticals

    Asthma

    phase 3 small molecule terminated

    1 trial
  14. BGF MDI 320/28.8/9.6 μg

    AstraZeneca

    Asthma

    phase 3 small molecule completed

    1 trial
  15. Beclomethasone Dipropionate 640

    Teva Pharma GmbH

    Persistent Asthma

    phase 3 small molecule completed

    1 trial
  16. Beclomethasone dipropionate

    Teva Pharma GmbH

    Asthma

    phase 3 small molecule completed

    2 trials
  17. Beclomethasone dipropionate BAI

    Teva Pharma GmbH

    Asthma

    phase 3 small molecule completed

    1 trial
  18. Beclomethasone dipropionate breath-actuated inhaler

    Teva Pharma GmbH

    Persistent Asthma

    phase 3 small molecule completed

    1 trial
  19. Benralizumab

    AstraZeneca

    Asthma

    phase 3 mab completed

    1 trial
  20. Budesonide

    AstraZeneca

    Asthma

    phase 3 small molecule completed

    1 trial
  21. Budesonide and formoterol fumarate dehydrate (BF) SPIROMAX

    Teva Pharma GmbH

    Asthma

    phase 3 small molecule completed

    1 trial
  22. Budesonide/Formoterol SPIROMAX®

    Teva Pharma GmbH

    Asthma

    phase 3 small molecule completed

    1 trial
  23. Budesonide/Formoterol fumarate dihydrate

    Teva Pharma GmbH

    Asthma

    phase 3 small molecule active

    1 trial
  24. Budesonide/formoterol Turbuhaler

    AstraZeneca

    Asthma

    phase 3 small molecule completed

    1 trial

Frequently asked questions

What is the Clinical Development Intelligence Platform?

It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.

How does this compare to Evaluate Pharma or Citeline?

Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.

Where does pipeline data come from?

Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.

Can I follow a company or program for updates?

Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.